Rashid Saman, Salim Asmat, Naeem Nadia, Haneef Kanwal
Dr. Zafar H. Zaidi Center for Proteomics, University of Karachi, Karachi, Pakistan.
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan.
Curr Protein Pept Sci. 2025;26(7):546-555. doi: 10.2174/0113892037343658241111051831.
Ex vivo preconditioning increases the therapeutic potential of mesenchymal stem cells (MSCs) in terms of antioxidant activity, growth factor production, homing, differentiation, and immunomodulation. Therefore, it is considered an effective strategy to be used before transplantation and therapeutic application of MSCs. Histone deacetylase inhibitor (HDACi), valproic acid (VPA), has been reported to induce hepatic differentiation in MSCs. Although individual studies have shown that preconditioning and epigenetic modification enhance the survival and differentiation of MSCs, the combined effects of these therapies have not been fully explored. This study aims to investigate the combined effect of hydrogen peroxide (HO) preconditioning and HDACi (valproic acid) on the differentiation of bone marrow-derived mesenchymal stem cells (BM-MSCs) into hepatic-like cells.
MSCs were first preconditioned with HO and then cultured with VPA. The migration and proliferation potential of the treated cells were evaluated using wound healing and colonyforming unit assays. Furthermore, the expression of hepatic genes ( and proteins (AFP, ALB, TAT) was evaluated in all treated groups.
The combined therapy group exhibited enhanced cell migration and proliferation, as evidenced by wound healing and colony-forming unit assays. Additionally, the combined treatment group showed higher expression of , and hepatic genes and TAT protein, suggesting an improved differentiation of stem cells into hepatocytes.
In conclusion, the combination of HO and VPA emerges as an important factor in promoting hepatocyte differentiation. However, further studies are required to optimize this protocol for future therapeutics.
体外预处理可增强间充质干细胞(MSCs)在抗氧化活性、生长因子产生、归巢、分化和免疫调节方面的治疗潜力。因此,它被认为是在MSCs移植和治疗应用前使用的一种有效策略。据报道,组蛋白去乙酰化酶抑制剂(HDACi)丙戊酸(VPA)可诱导MSCs向肝细胞分化。尽管个别研究表明预处理和表观遗传修饰可提高MSCs的存活率和分化能力,但这些疗法的联合效果尚未得到充分探索。本研究旨在探讨过氧化氢(HO)预处理和HDACi(丙戊酸)对骨髓间充质干细胞(BM-MSCs)向肝样细胞分化的联合作用。
首先用HO对MSCs进行预处理,然后用VPA进行培养。使用伤口愈合和集落形成单位试验评估处理后细胞的迁移和增殖潜力。此外,在所有处理组中评估肝基因(和蛋白质(AFP、ALB、TAT)的表达。
伤口愈合和集落形成单位试验证明,联合治疗组的细胞迁移和增殖增强。此外,联合治疗组显示肝基因和TAT蛋白的表达更高,表明干细胞向肝细胞的分化得到改善。
总之,HO和VPA的联合使用是促进肝细胞分化的一个重要因素。然而,需要进一步研究以优化该方案用于未来的治疗。